- Home
- BEEM vs SLGL Comparison
BEEM vs SLGL Comparison
Compare BEEM & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- SLGL
- Stock Information
- Founded
- BEEM 2006
- SLGL 1997
- Country
- BEEM United States
- SLGL Israel
- Employees
- BEEM N/A
- SLGL N/A
- Industry
- BEEM Semiconductors
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- SLGL Health Care
- Exchange
- BEEM Nasdaq
- SLGL Nasdaq
- Market Cap
- BEEM 23.4M
- SLGL 19.3M
- IPO Year
- BEEM N/A
- SLGL 2018
- Fundamental
- Price
- BEEM $1.73
- SLGL $7.38
- Analyst Decision
- BEEM Strong Buy
- SLGL Buy
- Analyst Count
- BEEM 4
- SLGL 1
- Target Price
- BEEM $5.33
- SLGL $40.00
- AVG Volume (30 Days)
- BEEM 1.1M
- SLGL 30.0K
- Earning Date
- BEEM 08-12-2025
- SLGL 08-15-2025
- Dividend Yield
- BEEM N/A
- SLGL N/A
- EPS Growth
- BEEM N/A
- SLGL N/A
- EPS
- BEEM N/A
- SLGL N/A
- Revenue
- BEEM $41,099,000.00
- SLGL $12,103,000.00
- Revenue This Year
- BEEM N/A
- SLGL N/A
- Revenue Next Year
- BEEM $38.51
- SLGL $31.17
- P/E Ratio
- BEEM N/A
- SLGL N/A
- Revenue Growth
- BEEM N/A
- SLGL 603.66
- 52 Week Low
- BEEM $1.33
- SLGL $3.34
- 52 Week High
- BEEM $7.68
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- BEEM 60.58
- SLGL 52.97
- Support Level
- BEEM $1.39
- SLGL $7.02
- Resistance Level
- BEEM $1.56
- SLGL $7.58
- Average True Range (ATR)
- BEEM 0.10
- SLGL 0.37
- MACD
- BEEM 0.02
- SLGL 0.02
- Stochastic Oscillator
- BEEM 81.09
- SLGL 41.28
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.